Contact Us
Contact Us
Home Finance Sunshine Biopharma reduces Series B warrant exercise price to $1.2046
Finance

Sunshine Biopharma reduces Series B warrant exercise price to $1.2046

September 11, 20261 Mins read1
Share
Sunshine Biopharma reduces Series B warrant exercise price to .2046
Share


Sunshine Biopharma reduces Series B warrant exercise price to $1.2046

Source link

Share
OppFi CEO Todd Schwartz buys ,313 in company stock Previous post OppFi CEO Todd Schwartz buys $25,313 in company stock

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
OpenAI agents linked to previously undisclosed cyberattack on RubyGems – WSJ
Finance

OpenAI agents linked to previously undisclosed cyberattack on RubyGems – WSJ

BySeptember 11, 2026
Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
Finance

Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports

BySeptember 11, 2026
Sl spv-2, l.p. sells million in Dell Technologies stock
Finance

Sl spv-2, l.p. sells $26 million in Dell Technologies stock

BySeptember 11, 2026
Sl spv-2, l.p. sells million in Dell Technologies stock
Finance

Brightline Interactive receives Nasdaq delisting notice for minimum bid price

BySeptember 11, 2026
© Copyright 2024 Jellywp. All rights reserved powered by Jellywp.com